Videos / Updated indications for the recombinant, adjuvanted RSV vaccine
In this Product Explainer Cardiologist Prof Andrew Sindone provides an update on a recombinant, adjuvanted respiratory syncytial virus (RSV) vaccine.
This educational video was developed by Healthed in collaboration with and with funding from GSK.
Views of the speaker are their own and do not necessarily reflect that of GSK. GSK recommends usage in accordance with the Product Information.
PM-AU-RSA-WCNT-250023. Date of approval: May 2025.

GLP 1s & Sarcopenia: Fact vs Hype

The New Dengue Vaccine – What You Need to Know

Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk

Management of Photoageing

expert
Cardiologist; Director, Heart Failure Unit, Department of Cardiac Rehabilitation, Concord Hospital; Head, Department of Cardiology, Ryde Hospital